B6.066 Paget Disease of the Bone Flashcards
sources of alk phos
bone
liver
placenta
physiologic states associated with alk phos elevation
post prandial (more common w certain blood types) pregnancy
what can help determine the source of alk phos
GGT
5-nucleotidase
bone specific alk phos
bilirubin, LFTs
GGT
elevation suggests cholestasis
5-nucleotidase
elevation suggests cholestasis
total bilirubin
elevation suggests liver path
elevated bone alk phos
indicative of high bone turnover
marker of osteoblastic activity
reasons bone alk phos may be elevated
pHPTH (high Ca) thyrotoxicosis osteomalacia (low vit D) malignancy of the bone (primary vs metastatic) Pagets
diagnostic step for Pagets after isolating bone alk phos
xray
radionuclide bone scan
xray findings in Pagets
bony overgrowth
thickened cortices marked by tunneling
accentuated trabeculae
bone scan findings in Pagets
increased metabolic activity
what is Pagets?
focal areas of increased and disorganized bone remodeling
- overactive osteoclastic bone resorption
- compensatory increase in osteoblastic new bone formation
result: structurally disorganized mosaic of bone
discuss the structure of bone in pagets
expanded
less compact
more vascular
more susceptible to fractures
preferential targets of Pagets
axial skeleton:
- pelvis
- femur
- lumbar spine
- skull
- tibia
osteocytes
osteoblasts that remain within cortical bone
orchestrate remodeling process of bone
sensors of mechanical loading
pagets epidemiology
rare before 55
5% of women, 8% of men by 8th decade of life
primarily Caucasian (rare in African, indian, Asian)
15% have positive family history
inheritance of pagets
AD fashion
incomplete penetrance
etiology of pagets
unknown
evidence for genetic and viral etiologies
how does pagets present?
incidental finding on radiology testing
asymptomatic biochemical testing
up to 40% have bone pain
how is paget diagnosed?
elevated alk phos, bone specific when fractionated
normal calcium
normal phos
normal PTH
indication for therapy in pagets
symptoms from active disease pagetic lesions involving weight bearing skeleton metabolically active lesions -bone turnover markers -bone scan potential consequence of bony overgrowth
bisphosphonate side effects
upper GI irritation severe musculoskeletal pain hypocalcemia uveitis / scleritis osteonecrosis of the jaw atypical femur fracture
zolendronic acid
IV formulation, potent, infuses over 15 minutes
most sustained response
-biochemical remission after one dose may be years long
oral bisphosphonate options for pagets
risedronate 30 mg once daily for 2 months
alendronate 40 mg daily for 6 months
when are bisphosphonates contraindicated
kidney disease
use calcitonin
goals of pagets therapy
ease bone pain
normalize rate of bone remodeling
outcome measures of pagets therapy
normalization of alk phos (3-6 months)
avoid structurally disorganized mosaic of bone
when to retreat pagets
recurrence of abnormal bone turnover
- serial alk phos measures
- radiographic progression
- recurrent pain